EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
6.48
+0.57 (9.75%)
Apr 22, 2025, 4:00 PM EDT - Market closed

EyePoint Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4475231,088119415100
Upgrade
Market Cap Growth
-51.95%-51.95%811.96%-71.25%316.71%-40.59%
Upgrade
Enterprise Value
992929588334125
Upgrade
Last Close Price
6.507.4523.113.5012.246.58
Upgrade
PS Ratio
8.4612.0823.642.8811.232.89
Upgrade
PB Ratio
1.321.554.091.242.255.37
Upgrade
P/TBV Ratio
1.331.554.091.242.57-
Upgrade
P/OCF Ratio
--580.20---
Upgrade
EV/Sales Ratio
2.296.7520.820.219.053.62
Upgrade
Debt / Equity Ratio
0.070.070.020.480.212.22
Upgrade
Asset Turnover
0.110.110.170.190.210.42
Upgrade
Inventory Turnover
7.147.142.7317.838.066.22
Upgrade
Quick Ratio
7.587.585.254.649.723.65
Upgrade
Current Ratio
7.827.825.455.0010.054.24
Upgrade
Return on Equity (ROE)
-43.42%-43.42%-39.04%-72.84%-57.58%-337.87%
Upgrade
Return on Assets (ROA)
-23.57%-23.57%-17.52%-22.24%-19.46%-28.30%
Upgrade
Return on Capital (ROIC)
-28.88%-28.88%-22.64%-26.94%-24.40%-39.32%
Upgrade
Earnings Yield
-29.27%-25.04%-6.51%-85.72%-14.08%-45.60%
Upgrade
FCF Yield
-29.14%-24.92%-0.15%-56.29%-12.11%-14.86%
Upgrade
Buyback Yield / Dilution
-44.71%-44.71%-4.25%-29.76%-124.04%-23.06%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q